ANTIBODY PERSISTENCE AFTER PRIMARY VACCINATION WITH A HEXAVALENT DTPa-HBV-IPV/HIB VACCINE COADMINISTERED WITH A MENINGOCOCCAL C-CRM197 VACCINE AND RESPONSE TO A DTPa-IPV/HIB BOOSTER AT 18 MONTHS OF AGE